The human ileum contains a high density of enteroendocrine L-cells, which release the appetite-suppressing hormones glucagon-like peptide-1 (GLP-1) and peptide tyrosine tyrosine (PYY) in response to food intake. Recent evidence highlighted the potential role of food structures in PYY release, but the link between food structures, ileal metabolites, and appetite hormone release remains unclear owing to limited access to intact human ileum. In a randomized crossover trial (ISRCTN11327221; isrctn.com ), we investigated the role of human ileum in GLP-1 and PYY release by giving healthy volunteers diets differing in fiber and food structure: high-fiber (intact or disrupted food structures) or low-fiber disrupted food structures. We used nasoenteric tubes to sample chyme from the intact distal ileum lumina of humans in the fasted state and every 60 min for 480 min postprandially. We demonstrate the highly dynamic, wide-ranging molecular environment of the ileum over time, with a substantial decrease in ileum bacterial numbers and bacterial metabolites after food intake. We also show that high-fiber diets, independent of food structure, increased PYY release compared with a low-fiber diet during 0 to 240 min postprandially. High-fiber diets also increased ileal stachyose, and a disrupted high-fiber diet increased certain ileal amino acids. Treatment of human ileal organoids with ileal fluids or an amino acid and stachyose mixture stimulated PYY expression in a similar profile to blood PYY concentrations, confirming the role of ileal metabolites in PYY release. Our study demonstrates the diet-induced changes over time in the metabolite environment of intact human ileum, which play a role in PYY release.
1 May 2019 in Current Problems in Diagnostic Radiology
Bladder cancer is a common malignancy but presentation with metastatic disease is rare. This is the fi rst reported case of duodenal obstruction as a presentation of metastatic bladder cancer. A middle-aged woman presented with nausea, vomiting, weight loss and intermittent haematuria. Radiology and histology confirmed metastatic bladder cancer to the retroperitoneum encasing the duodenum and causing obstruction. Insertion of a duodenal stent relieved the obstruction and palliative chemoradiotherapy was initiated. The patient died 15 months after diagnosis. Clinicians and radiologists should be aware of atypical presentations of common malignancies.
16 March 2026 in Laryngoscope Investigative Otolaryngology
Objectives: Jet phenomenon (JP) refers to a turbulent high‐flow jet of contrast agent passing through a narrow upper esophageal sphincter (UES) and is observed on fluoroscopic swallow studies in some patients with cricopharyngeal muscle dysfunction (CPMD). Pharyngeal high‐resolution manometry (Ph‐HRM) is a useful adjunct in assessing patients with CPMD and diagnosing UES dysfunction based on parameters highlighted in the international Leuven consensus. We propose a novel scoring system for JP and report on the Ph‐HRM findings in a cohort of CPMD patients with and without JP. Methods: Consecutive patients with CPMD who underwent Ph‐HRM were included in the study. Patients who received prior treatments were excluded. Patients were scored 1–4 based on fluoroscopic features of JP and divided into two groups according to the absence (jet score 1–2) or presence (jet score 3–4) of sustained JP. Ph‐HRM findings were compared between the groups. Results: Overall, 7 patients with and 13 without JP were included. Both integrated relaxation pressures (IRP) and intra‐bolus pressures (IBP) were significantly higher in the JP (+) group, 14.06 versus 3.92 ( p : 0.0040) and 25.57 versus 4.72 ( p : 0.0065), respectively. Pharyngeal, mesopharyngeal, and hypopharyngeal contractile integrals (PhCI, MCI, and HCI) were also significantly higher in the JP (+) group. IRP, PhCI, MCI, and HCI were significantly positively correlated with the severity of jet score. Conclusions: The presence of sustained JP (jet score 3–4) in patients with CPMD significantly correlates with higher contractile integrals at multiple pharyngeal anatomical subsites and UES dysfunction features on Ph‐HRM. Level of Evidence: 4.